Championing a Cure for PCD
Primary Ciliary Dyskinesia affects 1 in 15,000 people worldwide. Our mission is to accelerate research, improve diagnosis, and bring hope to those affected by this rare genetic disorder.
Primary Ciliary Dyskinesia affects 1 in 15,000 people worldwide. Our mission is to accelerate research, improve diagnosis, and bring hope to those affected by this rare genetic disorder.
Primary Ciliary Dyskinesia is a rare genetic disorder affecting the cilia - tiny, hair-like structures that line the airways.
Learn MoreCommon symptoms include chronic cough, recurring respiratory infections, and sinus problems. Diagnosis often requires specialized testing.
TreatmentsPCD is caused by mutations in over 40 different genes. Understanding the genetic basis is crucial for developing targeted treatments.
Explore GeneticsAlthough CurePCD is not currently accepting donations, the PCD Foundation helps fund critical research and support programs for PCD patients.
Donate NowConnect with other patients, families, and healthcare providers in our supportive community.
Join NowHelp raise awareness about PCD by sharing information and stories on social media.
Share Resources